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and presented a skewed distribution towards zero. B. Distribution of mean pIC 50 values for the compound-target combinations annotated with more than one bioactivity value. Mean pIC 50 values for those compound-target combinations annotated with more than one bioactivity value span the whole bioactivity range considered in this study. On the basis of these distributions, the mean of the repeated measurements was taken as the bioactivity value. Figure S2 . PCA of the compounds present in the PCM dataset. The first two principal components explained 51.77% of the variance, calculated on the pairwise Spearman's rank correlation matrix using the same compound descriptors that served to train the models. Overall, compounds are overall structurally similar across targets, as clusters are composed of compounds with bioactivities annotated against several targets. Therefore, the prediction of compound bioactivities by PCM will mainly rely on an appropriate description of the different DHFR binding sites. Table S1 and S2 are given in two additional files. 
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